Dual isotope SPECT in malignant Jacod's syndrome

Area of Science:

• Neurology
• Oncology
• Radiology

Background:

• Jacod's syndrome is a rare condition characterized by ophthalmoplegia, blindness, and trigeminal neuralgia.
• Metastatic tumors are a potential, though uncommon, cause of Jacod's syndrome.
• Conventional imaging like CT and MRI can face limitations in assessing soft tissue invasion at the orbital apex.

Observation:

• A patient presented with symptoms consistent with Jacod's syndrome.
• Abnormal soft tissue invasion was noted in the orbital apex, anterior clinoid process, and cavernous sinus.
• Computed tomography (CT) and magnetic resonance imaging (MRI) showed limitations in fully characterizing the extent of the lesion.

Findings:

• Dual-isotope single-photon emission computed tomography (SPECT) using technetium-99m hydroxymethylene diphosphonate (Tc-99m HMDP) bone imaging and thallium-201 (Tl-201) tumor imaging strongly suggested a small metastatic tumor as the cause.
• Anatomic imaging alone was insufficient for precise therapeutic effect assessment.
• Post-radiation therapy dual-isotope SPECT indicated a reduction in tumor viability.

Implications:

• Dual-isotope SPECT offers valuable diagnostic and therapeutic monitoring capabilities for rare conditions like metastatic Jacod's syndrome.
• This imaging technique can aid in evaluating treatment efficacy when conventional methods are limited.
• Early and accurate diagnosis through advanced imaging is critical for managing patients with metastatic tumors presenting with complex neurological syndromes.